U.S. FDA Grants RMAT Designation to GS-100, Grace Science’s Gene Therapy to Treat NGLY1 Deficiency
MENLO PARK, Calif., April 14, 2026--(BUSINESS WIRE)--Grace Science, LLC, a biotechnology company founded to develop novel therapies based on the function of NGLY1, announced today that the U.S. Food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results